验证数据展示
经过测试的应用
Positive FC detected in | mouse thymocytes |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
FITC-98077 targets CD155/PVR in FC applications and shows reactivity with mouse samples.
经测试应用 | FC Application Description |
经测试反应性 | mouse |
免疫原 | CD155/PVR fusion protein Eg0903 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Recombinant |
产品类型 | Antibody |
全称 | poliovirus receptor |
别名 | Pvr, 240731B1, CD155, poliovirus receptor, Tage4 |
计算分子量 | 45 kDa |
GenBank蛋白编号 | NM_027514.2 |
基因名称 | CD155/PVR |
Gene ID (NCBI) | 52118 |
偶联类型 | FITC Plus Fluorescent Dye |
最大激发/发射波长 | 495 nm / 524 nm |
形式 | Liquid |
纯化方式 | Protein A purification |
UNIPROT ID | Q8K094 |
储存缓冲液 | PBS with 0.09% sodium azide , pH 7.3 |
储存条件 | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
背景介绍
CD155, also known as the poliovirus receptor (PVR) or Necl-5, is one of the nectin-like family members, belonging to the Ca2+ independent immunoglobulin superfamily (IgSF) in cell adhesion molecules (PMID: 37660884). CD155 is a type I transmembrane protein composed of three extracellular immunoglobulin-like domains, a transmembrane domain, and a cytoplasmic tail. It is involved in cell-to-cell and cell-to-ECM adhesion (PMID: 32019260; 11437656). CD155 acts as a ligand for immune receptors, including TIGIT, CD96 and CD226, which are expressed on T cells and NK cells. CD155 interacts with these receptors to modulate immune responses, such as T cell activation and NK cell-mediated cytotoxicity (PMID: 37660884). CD155 serves as the entry receptor for poliovirus and thereby mediates susceptibility to poliovirus infection (PMID: 15034010).
实验方案
Product Specific Protocols | |
---|---|
FC protocol for FITC Plus CD155/PVR antibody FITC-98077 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |